Home › Funds › Encore Global Management, LP › REGN
Encore Global Management, LP position in REGN
REGENERON PHARMACEUTICALS · Health Care
Encore Global Management, LP reported holding 500 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$379K, representing 0.42% of its reported portfolio and ranking #43 among its reported holdings. Encore Global Management, LP has disclosed REGN holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR
How Encore Global Management, LP's REGN position evolved
Encore Global Management, LP first disclosed a stake in REGN in Q1 2026 at 1,100 shares (US$850K). The position peaked in Q2 2026 at 5,050 shares, worth US$3.1M. Across 3 filings, Encore Global Management, LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 500 shares valued at US$379K — a reduction of -4,550 shares quarter over quarter.. Notable position changes include a 359% increase in Q2 2026 (shares rose 22% over the following quarter), a 90% trim in Q3 2026 (shares rose 27% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 1.10K | $849.90K | New |
| Q2 2026 | 5.05K | $3.15M | Add |
| Q3 2026 | 500 | $379.13K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About REGN and 13F data
REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 30 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), Nuveen, LLC (US$1.48B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding REGN
- Dodge & Cox 4.87M sh · $3.04B · Q2 2026
- DODGE & COX 4.87M sh · $3.04B · Q2 2026
- Nuveen, LLC 1.96M sh · $1.48B · Q3 2026
- LOOMIS SAYLES & CO L P 1.86M sh · $1.16B · Q2 2026
More on Encore Global Management, LP
FAQ
How long has Encore Global Management, LP held REGN?
Encore Global Management, LP has disclosed REGN holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Encore Global Management, LP's current position in REGN?
As of Q3 2026, Encore Global Management, LP holds 500 shares of REGN (REGENERON PHARMACEUTICALS), valued at $379.13K, representing 0.42% of its reported portfolio and ranking #43.
Has Encore Global Management, LP been buying or selling REGN?
In the latest 13F filing (Q3 2026), Encore Global Management, LP reduced its position in REGN. The position peaked in Q2 2026 at 5.05K shares.
Which other funds hold REGN?
Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, Nuveen, LLC, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.